Advertisement
Advertisement
U.S. markets open in 1 hour 8 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Lucira Health, Inc. (LHDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1900+0.1600 (+5.28%)
At close: 04:00PM EDT
3.3800 +0.19 (+5.96%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close3.0300
Open3.3600
Bid2.7500 x 1200
Ask3.1900 x 900
Day's Range3.1300 - 3.3600
52 Week Range1.3600 - 10.6500
Volume30,116
Avg. Volume78,480
Market Cap127.179M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.9900
Earnings DateAug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LHDX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Lucira Health, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/14/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    29 days agoArgus Research
View more
  • GlobeNewswire

    Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test

    Lucira COVID-19 & Flu Test – the 99% Accurate At-Home Test for Covid and Flu The first and only at-home test authorized by Health Canada for both Covid and Flu, the Lucira COVID-19 & Flu Test provides 99% accurate results compared to highly sensitive lab-based tests, but in only 30 minutes – at home. Lucira COVID-19 & Flu Test – All You Need to Answer “Is it Covid or the Flu?” Flu is back, and COVID hasn’t gone anywhere, and it can be hard to tell what you have. The Lucira COVID-19 & Flu Test is

  • GlobeNewswire

    Lucira Health to Announce Second Quarter 2022 Financial Results

    EMERYVILLE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report second quarter 2022 financial results on, Monday, August 15, 2022. Lucira’s management will host a conference call and webcast at 1:30 p.m. PT / 4:30 p.m. ET that day to discuss the financial results and provi

  • GlobeNewswire

    Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    EMERYVILLE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests today announced that on July 27, 2022, the Board of Directors of Lucira granted inducement awards consisting of 1,051,405 restricted stock units (“RSUs”) under Lucira’s 2022 Inducement Plan. The Board of Directors approved the awards as an inducement material to

Advertisement
Advertisement